Chimerix Inc (CMRX)

NASDAQ
7.210
+0.270(+3.89%)
  • Volume:
    80,519
  • Bid/Ask:
    7.200/7.210
  • Day's Range:
    7.060 - 7.230

CMRX Overview

Prev. Close
6.94
Day's Range
7.06-7.23
Revenue
5.57M
Open
7
52 wk Range
2.22-11.39
EPS
-1.75
Volume
80,519
Market Cap
619M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
750,988
P/E Ratio
-
Beta
1.55
1-Year Change
109.67%
Shares Outstanding
86,211,412
Next Earnings Date
Aug 09, 2021
What is your sentiment on Chimerix Inc?
or
Vote to see community's results!

Chimerix Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyBuyStrong SellStrong Buy

Chimerix Inc Company Profile

Chimerix Inc Company Profile

Employees
54

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox; dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy; and ONC201 a program for potentially treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Read More
  • looks weak
    0
    • Anyone?
      0
      • Anybody in here? The -81% was an opportunity to enter at ~7$
        0
        • everyone is on stocktwits for this
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.